This slide shows the cost per diagnosis of selected mental disorders in Europe in 2010. Due to the relative high number of persons diagnosed and the relative high cost per patient, mood disorders ranks as number 1 of the diseases contributing to the total costs of mental or neurological disorders in Europe.
The report covers the 27 EU countries plus Switzerland, Norway, and Iceland. The wider spectrum of mood disorders (also labeled affective disorders), include two particularly important diagnoses with large societal costs; namely major depression and bipolar disorder.
Variations in the epidemiological data covering mood disorders across studies from various European countries are primarily explained by varying study designs whereas the true differences across countries are small. Therefore, data is based on the median European best estimates of the prevalence rates for all countries. That is, 6.9% for major depression (age 18+) and 0.9% for bipolar disorder (age 18–65).
In the 27 EU countries plus Norway, Iceland and Switzerland with a total population of 514 million people, the total cost of disorders of the brain was estimated to be €798 billion per year. This cost burden corresponds to 25% of the direct health care expenses and the non-medical direct cost as well as the indirect costs, such as lost work time, are higher than for most other diseases due to the persisting nature of many brain diseases. In total, probably one third of all health related expenses are caused by brain disorders. Mood disorders was the largest contributor with cost estimated to be €113405 million (ppp).